Department of Intensive Care Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
PLoS One. 2024 Jun 3;19(6):e0300602. doi: 10.1371/journal.pone.0300602. eCollection 2024.
Describing mitochondrial oxygenation (mitoPO2) and its within- and between-subject variability over time after 5-aminolevulinic acid (ALA) plaster application in healthy volunteers.
Prospective cohort study.
Measurements were performed in Leiden University Medical Center, the Netherlands.
Healthy volunteers enrolled from July to September 2020.
Two ALA plasters were placed parasternal left and right, with a 3-hour time interval, to examine the influence of the calendar time on the value of mitoPO2. We measured mitoPO2 at 4, 5, 7, 10, 28, and 31 hours after ALA plaster 1 application, and at 4, 5, 7, 25, and 28 hours after ALA plaster 2 application.
At each time point, five mitoPO2 measurements were performed. Within-subject variability was defined as the standard deviation (SD) of the mean of five measurements per timepoint of a study participant. The between-subject variability was the SD of the mean mitoPO2 value of the study population per timepoint.
In 16 completed inclusions, median mitoPO2 values and within-subject variability were relatively similar over time at all time points for both plasters. An increase in overall between-subject variability was seen after 25 hours ALA plaster time (19.6 mm Hg vs 23.9 mm Hg after respectively 10 and 25 hours ALA plaster time).
The mitoPO2 values and within-subject variability remained relatively stable over time in healthy volunteers. An increase in between-subject variability was seen after 25 hours ALA plaster time warranting replacement of the ALA plaster one day after its application.
ClinicalTrials.gov with trial number NCT04626661.
描述健康志愿者在应用 5-氨基酮戊酸(ALA)贴剂后,线粒体氧合(mitoPO2)及其随时间的个体内和个体间变异性。
前瞻性队列研究。
荷兰莱顿大学医学中心。
2020 年 7 月至 9 月期间招募的健康志愿者。
在胸骨旁左侧和右侧各放置 2 个 ALA 贴剂,间隔 3 小时,以研究日历时间对 mitoPO2 值的影响。我们在 ALA 贴剂 1 应用后 4、5、7、10、28 和 31 小时以及 ALA 贴剂 2 应用后 4、5、7、25 和 28 小时测量 mitoPO2。
在每个时间点,进行了 5 次 mitoPO2 测量。个体内变异性定义为研究参与者每个时间点五次测量的平均值的标准差(SD)。个体间变异性是研究人群每个时间点平均 mitoPO2 值的 SD。
在 16 例完成的纳入中,两种贴剂在所有时间点的中位数 mitoPO2 值和个体内变异性随时间相对相似。ALA 贴剂时间为 25 小时后,整体个体间变异性增加(ALA 贴剂时间分别为 10 小时和 25 小时后为 19.6mmHg 和 23.9mmHg)。
健康志愿者的 mitoPO2 值和个体内变异性随时间相对稳定。ALA 贴剂时间为 25 小时后,个体间变异性增加,需要在应用 ALA 贴剂一天后更换。
ClinicalTrials.gov,试验编号 NCT04626661。